Back to search

Netherlands· NL-6ae512ace37d

Albert Heijn Diclofenac 1%, gel

A diclofenac product containing diclofenac natrium, registered in Netherlands by Healthypharm B.V.. The same ATC class is registered in 14 of our 19 countries.

ATC M02AA15

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAlbert Heijn Diclofenac 1%, gelATCM02AA15REGISTER NO.NL-6ae512ace37dPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Diclofenac is registered in 14 of 19 countries.

Countries holding a registration under ATC M02AA15 (diclofenac), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose

Diclofenac · ATC M02AA15

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of diclofenac costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Diclofenac · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.43
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DICLOFENAC NATRIUM
Manufacturer
Healthypharm B.V.
Country
Netherlands (NL)
ATC code
M02AA15
ATC class
Diclofenac
Defined daily dose
0.1 g, T
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    124737

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

131 interactions on record for diclofenac.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Diclofenac · interactions on record

131 records

  • 9 severe
  • 122 moderate

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • PexidartinibL01EX15severe
  • LeflunomidL04AA13severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Diclofenac in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All diclofenac products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Dedolor Akut, Dedolor Drs
  • Belgium · Cataflam, Dicloabak
  • Bulgaria · Diclofenac-Tchaikapharma, Алмирал
  • Cyprus · Almiral, Areston
  • Czechia · Almiral, Dicloabak
  • Germany · Arthrex Schmerzgel, Diclac
  • Denmark · Diclodan, Diclofenac Bluefish
  • Estonia · Almiral, Dagesil
  • Spain · Cinfadol, Dagesil
  • Finland · Dicloabak, Diclomex Rapid
  • France · Antalcalm, Diclamine
  • United Kingdom (Northern Ireland) · Akis, Amgesic Muscle & Back Pain Relief
  • Greece · Batafil, Denaclof
  • Croatia · Diclac Duo, Diclo Duo
  • Hungary · Algoplast, Cataflam
  • Ireland · Cataflam, Diclac
  • Iceland · Diclofenac Alvogen, Dimax
  • Italy · Brexiadvance, Dealgic
  • Lithuania · Dagesil, Diclac
  • Luxembourg · Cataflam, Dicloabak
  • Latvia · Almiral, Dagesil
  • Malta · Almiral, Areston
  • Norway · Cataflam, Diclofenac Bluefish
  • Poland · Adarostin, Akis
  • Portugal · Dagesil, Dicipan
  • Romania · Almiral, Clafen
  • Sweden · Dicloabak, Diclofenac Bluefish
  • Slovenia · Diclo Duo, Dicloflex
  • Slovakia · Akis Plus, Almiral

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c7607c3d-9d70-42aa-9a87-f623cfe591ad
GET /v1/drugs/c7607c3d-9d70-42aa-9a87-f623cfe591ad?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Gel",
  "route": "Cutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h124737_smpc.pdf",
  "strength": null,
  "atc_label": "Diclofenac",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg124737",
  "excipients": [
    "CARBOMEER (TYPE UNKNOWN)",
    "HYDROXYETHYLCELLULOSE",
    "METHYLPARAHYDROXYBENZOAAT (E 218)",
    "NATRIUMHYDROXIDE (E 524)",
    "PROPYLEENGLYCOL (E 1520)",
    "PROPYLPARAHYDROXYBENZOAAT",
    "TRIGLYCERIDEN MIDDELLANGE KETEN",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "DICLOFENAC NATRIUM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h124737.pdf",
  "authorised_at": "2019/06/13",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend apotheek of drogist",
  "registration_number": "124737",
  "additional_monitoring": "N"
}

See everything about diclofenac.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.